Table 3.
Genetic loci demonstrating genome-wide association with maternal metabolic traits
Gene | Chromosome | Encoded protein | Protein function | Associated maternal trait | Associated metabolic traits in non-gravid populations |
---|---|---|---|---|---|
G6PC2 | 2 | Glucose-6-phosphatase, catalytic, 2 | Component of an integral membrane system that catalyses glucose-6- phosphate hydrolysis | Fasting glucose | Fasting glucose |
GCKR | 2 | Glucokinase regulator | Regulatory protein that inhibits glucokinase by forming an inactive complex with the enzyme | Fasting C-peptide, fasting glucose | Lipid phenotypes, fasting glucose, 2-h glucose, fasting insulin, Type 2 diabetes |
PCSK1 | 5 | Proprotein convertase subtilisin/kexin type 1 | Calcium-dependent serine endoprotease involved in proteolytic activation of several precursor proteins including proinsulin, pro- glucagon-like peptide 1 and pro-opiomelancortin, among others | Fasting glucose | Findings not consistent but associated with obesity-related traits, fasting plasma glucose, 2-h plasma glucose, and fasting and post-glucose proinsulin levels |
PPP1R3B | 8 | Protein phosphatase 1, regulatory subunit 3B | Facilitates interaction of protein phosphatase 1 with enzymes of glycogen metabolism | Fasting C-peptide, fasting glucose | Lipid phenotypes, fasting glucose, C-reactive protein, Type 2 diabetes |
HKDC1 | 10 | Hexokinase domain containing 1 | Structure consistent with a hexokinase, but function not yet defined | 2-h glucose | Nominal association with 2-h glucose in a meta-analysis of over 40 000 individuals |
MTNR1B | 11 | Melatonin receptor 1B | G-protein coupled receptor that is expressed on β-cells, binds melatonin and may antagonize insulin release | Fasting glucose, 1-h glucose | Fasting glucose, impaired fasting glucose, Type 2 diabetes, altered β-cell function, including decreased insulin release following oral and intravenous glucose |
BACE2 | 21 | β-site amyloid polypeptide cleaving enzyme 2 | Not defined | Fasting C-peptide | None reported |